Manufacturing · India · 27 Employees
View Company Info for Free
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge scie nce, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan.Read more
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Biocon Biologics has new funding data
Click to see if Biocon Biologics had a recent Job posting/layoffs
Check if Biocon Biologics has recently received funding, and reach out quickly before it becomes old news!
Biocon Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Biocon Biologics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Biocon Biologics launches new products
Check out if Biocon Biologics is spiking on competitors!
Earning: See what the market has to say on Biocon Biologics recently announced quarterly report
Recommended Actions
Find VP level buyers at Biocon Biologics
Find 2 more new buyers
View Biocon Biologics’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
A closer look at the technologies used by Biocon Biologics
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules acr... Read More
